Notice Of Inent to Sole Source (Promega Corporation)

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Promega Corporation.

The following enzymes are needed for protein digestion to determine the concentration of hemoglobin adducts of formaldehyde in the U.S. population from NHANES study, as part of the program biomonitoring activities performed in compliance to CLIA requirements in the Protein Biomarkers Laboratory of the Clinical Chemistry Branch.

• 1,400 vials of Promega Trypsin Gold, Mass Spectrometry Grade, packed in 100 microgram (µg) vials.

The requested trypsin quantities are critical to ensure uninterrupted laboratory operation for analyzing and reporting the study samples in a time efficient manner.
Insert the capability required that makes it a sole source. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at hsz5@cdc.gov by 5:00 pm Eastern Standard Time, 21 Aug 2018.

.